Discontinuation report MINT-LEVOFLOXACIN
Report ID | 170853 |
Drug Identification Number | 02505797 |
Brand name | MINT-LEVOFLOXACIN |
Common or Proper name | Levofloxacin |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | LEVOFLOXACIN |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 count bottles |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-10-02 |
Remaining supply date | 2022-11-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2022-10-03 | English | Compare |
v2 | 2022-10-02 | French | Compare |
v1 | 2022-10-02 | English | Compare |
Showing 1 to 3 of 3